A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer

BACKGROUND: Few studies have investigated the clinical efficacy of third- and later-line of chemotherapy after standard chemotherapy for previously treated advanced non-small cell lung cancer (NSCLC). We prospectively evaluated the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-pa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Chemother Pharmacol
Main Authors: Kato, Yasuhiro, Okuma, Yusuke, Watanabe, Kageaki, Yomota, Makiko, Kawai, Shoko, Hosomi, Yukio, Okamura, Tatsuru
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6647220/
https://ncbi.nlm.nih.gov/pubmed/30993397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-019-03843-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki